Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream BID for the Treatment of Signs and Symptoms of Dry Eye Disease

NCT05119920 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.

NCT NCT05119920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05119920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream BID for the Treatment of Signs and Symptoms of Dry Eye Disease
Lead sponsor
Glaukos Corporation
Phase
Phase 2
Overall status
Completed
Start date
January 3, 2022
Completion date
July 27, 2022
Enrollment
226 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease, kerato conjunctivitis sicca